bpc 157 fda compounding category This just in: The is proposing to move 14 commonly used peptides from 2 to Category 1 on the review list 🤯 If finalized, this shift could significantly change This is the first vote
This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make FDA removes BPC 157, KPV, Semax from Category 2 on April 22 but they are not legal to compound yet PeptideKnow The FDA just put peptides like BPC 157, TB 500, and KPV on the clock. As a compounding pharmacist, this is literally my world and most people don't understand the regulatory nuance behind HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

